A top-tier US news outlet — think New York Times, Washington Post, Wall Street Journal, or The Atlantic — will publish an investigative piece about named Republican politicians or operatives who have financial stakes in psychedelic startups. The piece will document conflicts of interest: these politicians push psychedelic policy or funding while their allies or allies' companies stand to profit. This matters because it exposes how money shapes drug policy and could derail the Republican push to legalize psychedelics.
Two independent editorial signals — repeated coverage of the 'Republican Psychedelics Whisperer' and billionaire performance-drug framing — suggest an investigative piece is already in progress. The specific falsifiability criteria: named Republican, named company, top-10 outlet (NYT, WaPo, WSJ, Atlantic, etc.), published before September 1. Drops if no named individuals or if published by smaller outlets only.